Key Takeaways Masayoshi Son, founder and CEO of Japanese multinational investment company SoftBank Group,has an estimated net ...

Not far from the storied venture capital firms on Sand Hill Road, there’s a palatial estate where Masayoshi Son, Silicon Valley’s newest kingmaker, shapes the future. Reaching him requires ...

Billionaire Masayoshi Son has a vision for the future of the world. But what does that vision look like? Lionel Barber is the former editor-in-chief of The Financial Times and author of the book ...

‘Gambling Man’ author Lionel Barber explains how Masayoshi Son went from losing money on WeWork to betting big on AI. Masayoshi Son is back on top. On January 22, President Donald Trump ...

Masayoshi Son, the CEO of the Japanese multinational investment company SoftBank, has pledged a hefty investment deal with Donald Trump for the U.S. On December 16, 2024, the two jointly announced ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

There's a new power couple in the world of artificial intelligence. The relationship between SoftBank CEO Masayoshi Son and Sam Altman, the head of OpenAI, is built on what could be the biggest ...

SoftBank Group CEO Masayoshi Son has made a strategic pivot toward the US market, appearing alongside President Donald Trump twice since his November election victory to unveil major investment plans.

From left: Masayoshi Son, chairman and CEO of SoftBank; Larry Ellison, executive chairman of Oracle; and Sam Altman, CEO of OpenAI listen to President Trump speak at the White House on Jan. 21 ...

SoftBank CEO Masayoshi Son speaks at a White House press conference on President Donald Trump's plan for AI infrastructure investment. MASA SON, SOFTBANK: Oh, thank you. That would be helpful.

SoftBank's billionaire chief executive Masayoshi Son and Trump are expected to jointly ... will arrive in a decade, bringing new inventions, new medicine, new knowledge and new ways to invest.